TD Securities upgraded shares of Vitalhub (TSE:VHI – Free Report) to a strong-buy rating in a report issued on Monday,Zacks.com reports.
Separately, Cormark upped their price target on shares of Vitalhub from C$9.50 to C$10.50 and gave the stock a “buy” rating in a report on Wednesday, October 2nd.
Read Our Latest Research Report on VHI
Vitalhub Price Performance
Vitalhub Company Profile
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Further Reading
- Five stocks we like better than Vitalhub
- Trading Stocks: RSI and Why it’s Useful
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What Are Dividend Achievers? An Introduction
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Why is the Ex-Dividend Date Significant to Investors?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.